干扰素基因刺激蛋白在慢性肝病发生发展中的抑制作用

张雪; 李曼; 张鑫; 孙学华; 朱晓骏; 高亚婷; 高月求

doi:10.3969/j.issn.1001-5256.2019.05.049

干扰素基因刺激蛋白在慢性肝病发生发展中的抑制作用

DOI: 10.3969/j.issn.1001-5256.2019.05.049

上海中医药大学附属曙光医院肝病科临床免疫研究所

基金项目:

国家自然科学基金(81673938,81774256,81473477,81503545)；国家“艾滋病和病毒性肝炎等重大传染病防治”科技重大专项(2012ZX10005004-002)；上海市科委科技支撑项目(16401970600);上海市科委生物引导项目(16401931300)；上海申康市级医院新兴前沿技术联合攻关项(SHDC12016121)；中医优势病种培育项目(zybz-2017004)；上海市中医药新兴交叉学科资助计划；

详细信息

中图分类号: R575
计量
- 文章访问数: 1226
- HTML全文浏览量: 24
- PDF下载量: 289
- 被引次数: 0
出版历程
- 收稿日期: 2018-11-22
- 出版日期: 2019-05-20

Stimulator of interferon genes inhibits the development and progression of chronic liver diseases

Department of Hepatology & Institute of Clinical Immunology, Shuguang Hospital Affiliated to Shanghai University of Traditional Chinese Medicine

Research funding:

摘要

摘要: 干扰素基因刺激蛋白(STING)是调节肝脏内环境的一种重要先天胞质环状二核苷酸传感器,主要通过天然免疫应答,特异性T淋巴细胞应答和自噬等激活干扰素调节因子(IRF) 3/IRF7,抑制慢性乙型肝炎、肝纤维化和肝细胞癌等慢性肝病的发生与发展。介绍了STING的分布、结构特点、生物学功能、信号通路及其在慢性肝病发生发展中的作用,旨在阐述STING在干预慢性肝病中的作用,从而在研究治疗中取得新思路。
- 干扰素基因刺激蛋白 /
- 肝疾病 /
- 信号传导 /
- 免疫,天然 /
- 综述
Abstract: Stimulator of interferon genes ( STING) is an important congenital cytoplasmic cyclic dinucleotide sensor that regulates the internal environment of the liver. It activates IRF3/IRF7 and inhibits the development and progression of chronic liver diseases such as chronic hepatitis B, liver fibrosis, and hepatocellular carcinoma through innate immune response, specific T cell response, and autophagy. This article introduces the distribution, structural characteristics, biological functions, and signaling pathways of STING and its role in the development and progression of chronic liver diseases, in order to elaborate on the role of STING in the intervention of chronic liver diseases and provide new ideas for treatment.
- STING /
- liver diseases /
- signal transduction /
- immunity, natural /
- review

HTML全文

参考文献(63)

[1] ISHIKAWA H, BARBER GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling[J]. Cytokine, 2009, 48 (1-2) :674-678.

[2] SOKOLOWSKA O, NOWIS D. STING signaling in cancer cells:Important or not?[J]. Arch Immunol Ther Exp (Warsz) , 2017, 66 (2) :125-132.

[3] BANETE A, SEAVER K, BAKSHI D, et al. On taking the STING out of immune activation[J]. J Leukoc Biol, 2018, 103:1189-1195.

[4] ZHONG B, YANG Y, LI S, et al. The adaptor protein MITA links virus-sensing receptors to IRF3 transcription factor activation[J]. Immunity, 2008, 29 (4) :538-550.

[5] SUN W, LI Y, CHEN L, et al. ERIS, an endoplasmic reticulum IFN stimulator, activates innate immune signaling through dimerization[J]. Proc Natl Acad Sci U S A, 2009, 106 (21) :8653-8658.

[6] QIAO JT, CUI C, QING L, et al. Activation of the STINGIRF3 pathway promotes hepatocyte inflammation, apoptosis and induces metabolic disorders in nonalcoholic fatty liver disease[J]. Metabolism, 2018, 81:13-24.

[7] JIN L, XU LG, YANG IV, et al. Identification and characterization of a loss-of-function human MPYS variant[J]. Genes Immun, 2011, 12 (4) :263-269.

[8] XU YY, WANG YY, XU HG, et al. Identification and characterization of stimulator of interferon gene promoter[J]. Acta Univ Med Nanjing:Natural Sci, 2016, 36 (7) :783-787. (in Chinese) 徐妍妍, 王艳艳, 徐华国, 等.小鼠STING基因启动子的克隆鉴定及功能初步分析[J].南京医科大学学报:自然科学版, 2016, 36 (7) :783-787.

[9] KRANZUSCH PJ, WILSON SC, LEE AS, et al. Ancient origin of cGAS-STING reveals mechanism of universal 2', 3'cGAMP signaling[J]. Mol Cell, 2015, 59 (6) :891-903.

[10] OUYANG S, SONG X, WANG Y, et al. Structural analysis of the STING adaptor protein reveals a hydrophobic dimer interface and mode of cyclic di-GMP binding[J]. Immunity, 2012, 36 (6) :1073-1086.

[11] LIU X, WANG C. The emerging roles of the STING adaptor protein in immunity and diseases[J]. Immunology, 2016, 147 (3) :285-291.

[12] WARNER JD, IRIZARRYCARO RA, BENNION BG, et al. STINGassociated vasculopathy develops independently of IRF3 in mice[J]. J Exp Med, 2017, 214 (11) :3279-3292.

[13] DAHAL LN, DOU L, HUSSAIN K, et al. STING activation reverses lymphoma-mediated resistance to antibody immunotherapy[J]. Cancer Res, 2017, 77 (13) :3619-3631.

[14] OGAWA E, MUKAI K, SAITO K, et al. The binding of TBK1 to STING requires exocytic membrane traffic from the ER[J].Biochem Biophys Res Commun, 2018, 503 (1) :138-145.

[15] TAKASHIMA K, OSHIUMI H, MATSUMOTO M, et al. TICAM-1 is dispensable in STING-mediated innate immune responses in myeloid immune cells[J]. Biochem Biophys Res Commun, 2018, 499 (4) :985-991.

[16] CUI X, CLARK DN, LIU K, et al. Viral DNA-dependent induction of innate immune response to hepatitis B virus in immortalized mouse hepatocytes[J]. J Virol, 2015, 90 (1) :486-496.

[17] THOMSEN MK, NANDAKUMAR R, STADLER D, et al. Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection[J]. Hepatology, 2016, 64 (3) :746-759.

[18] SAITOH T, FUJITA N, HAYASHI T, et al. Atg9a controls dsDNA-driven dynamic translocation of sting and the innate immune response[J]. Proc Natl Acad Sci U S A, 2010, 106 (3) :20842-20846.

[19] KONNO H, KONNO K, BARBER GN. Cyclic di nucleotides trigger ULK1 (ATG1) phosphorylation of STING to prevent sustained innate immune signaling[J]. Cel, 2013, 155 (3) :688-698.

[20] ISHIKAWA H, BARBER GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling[J]. Cytokine, 2009, 48 (1-2) :674-678.

[21] WATSON RO, MANZANILLO PS, COX JS. Extracellular M. tuberculosis DNA targets bacteria for autophagy by activating the host DNA-sensing pathway[J]. Cell, 2012, 150 (4) :803-815.

[22] ISHIKAWA H, BARBER GN. STING is an endoplasmic reticulum adaptor that facilitates innate immune signalling[J]. Nature, 2008, 455 (7213) :674-678..

[23] ISHIKAWA H, MA Z, BARBER GN. STING regulates intracellular DNA-mediated, type I interferon-dependent innate immunity[J]. Nature, 2009, 461 (7265) :788-792..

[24] LUO WW, LI S, LI C, et al. iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING[J]. Nat Immunol, 2016, 17 (9) :1057-1066.

[25] ZEVINI A, OLAGNIER D, HISCOTT J. Crosstalk between cytoplasmic RIG-I and STING sensing pathways[J]. Trends Immunol, 2017, 38 (3) :194-205.

[26] KWON D, SESAKI H, KANG SJ. Intracellular calcium is a rheostat for the STING signaling pathway[J]. Biochem Biophys Res Commun, 2018, 500 (2) :497-503.

[27] THOMSEN MK, NANDAKUMAR R, STADLER D, et al. Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection[J]. Hepatology, 2016, 64 (3) :746-759.

[28] MA Z, DAMANIA B. The cGAS-STING defense pathway and its counteraction by viruses[J]. Cell Host Microbe, 2016, 19 (2) :150-158.

[29] GALLUZZI L, VANPOUILLE-BOX C, BAKHOUM SF, et al.SnapShot:CGAS-STING signaling[J]. Cell, 2018, 173 (1) :276-276. e1.

[30] ZHANG J, HU MM, WANG YY, et al. TRIM32 protein modulates type I interferon induction and cellular antiviral response by targeting MITA/STING protein for K63-linked ubiquitination[J]. J Biol Chem, 2012, 287 (34) :28646-28655.

[31] WANG Q, LIU X, CUI Y, et al. AMFR and INSIG1 bridge adaptor STING and kinase TBK1 by catalyzing K27-linked polyubiquitination of STING on endoplasmic reticulum[J]. Immunity, 2014, 6 (41) :919-933.

[32] CHEN Q, SUN L, CHEN ZJ. Regulation and function of the cGAS-STING pathway of cytosolic DNA sensing[J]. Nat Immunol, 2016, 17 (10) :1142-1149.

[33] PEI RJ, CHEN XW, LU MJ. Control of hepatitis B virus replication by interferons and Toll-like receptor signaling pathways[J]. World J Gastroenterol, 2014, 20 (33) :11618-11629.

[34] BAI J, CERVANTES C, LIU J, et al. DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mt DNA release-activated cGAS-cGAMP-STING pathway[J]. Proc Natl Acad Sci U S A, 2017, 114 (46) :12196-12201.

[35] THOMSEN MK, NANDAKUMAR R, STADLER D, et al. Lack of immunological DNA sensing in hepatocytes facilitates hepatitis B virus infection[J]. Hepatology, 2016, 64 (3) :746-759.

[36] ANGHELINA D, LAM E, FALCKPEDERSEN E. Diminished antiviral innate response to Adenovirus vectors in cGAS/STING deficient mice minimally impacts adaptive immunity[J]. J Virol, 2016, 90 (13) :5915.

[37] GUO F, TANG L, SHU S, et al. Activation of STING in hepatocytes suppresses the replication of hepatitis B virus[J]. Antimicrob Agents Chemother, 2017, 61 (10) :e00771-17.

[38] LEI Z, DENG M, YI Z, et al. cGAS-mediated autophagy protects the liver from ischemia/reperfusion injury independent of STING[J]. Am J Physiol Gastrointest Liver Physiol, 2018, 314 (6) :g655-g667.

[39] GUO F, HAN Y, ZHAO X, et al. STING agonists induce an innate antiviral immune response against hepatitis B virus[J].Antimicrob Agents Chemother, 2015, 59 (2) :1273-1281.

[40] GUO X, CHANG S, LI H, et al. Cyclic GMP-AMP ameliorates diet-induced metabolic dysregulation and regulates proinflammatory responses distinctly from STING activation[J]. Sci Rep, 2017, 7 (1) :6355.

[41] HWANG J, KANG T, LEE J, et al. Design, synthesis, and biological evaluation of C7-functionalized DMXAA derivatives as potential human-STING agonists[J]. Org Biomol Chem, 2019, 17 (7) :1869-1874.

[42] ZHENG LB, WANG J, MAO Y, et al. A novel stimulator of interferon gene (STING) from Larimichthys crocea and their involvement in immune response to ectoparasite Cryptocaryon irritans infection[J]. Fish Shellfish Immunol, 2017, 71:239-245.

[43] KIM S, LI L, MALIGA Z, et al. Anticancer flavonoids are mouse selective STING agonists[J]. ACS Chem Biol, 2013, 8 (7) :1396-1401.

[44] IWASAKI A, MEDZHITOV R. Regulation of adaptive immunity by the innate immune system[J]. Science, 2010, 327 (5963) :291-295.

[45] LIU S, ZHAO K, SU X, et al. MITA/STING and its alternative splicing isoform MRP restrict hepatitis B virus replication[J].PLo S One, 2017, 12 (1) :e0169701.

[46] BAI J, CERVANTES C, LIU J, et al. DsbA-L prevents obesity-induced inflammation and insulin resistance by suppressing the mt DNA release-activated cGAS-cGAMP-STING pathway[J]. Proc Natl Acad Sci U S A, 2017, 114 (46) :12196-12201.

[47] CERBONI S, JEREMIAH N, GENTILI M, et al. Intrinsic antiproliferative activity of the innate sensor STING in T lymphocytes[J]. J Exp Med, 2017, 214 (6) :1769-1785.

[48] IRACHETA-VELLVE A, PETRASEK J, GYONGYOSI B, et al.Endoplasmic reticulum stress-induced hepatocellular death pathways mediate liver injury and fibrosis via Stimulator of Interferon Genes[J]. J Biol Chem, 2016, 291 (52) :26794.

[49] KRIZHANOVSKY V, YON M, DICKINS RA, et al. Senescence of activated stellate cells limits liver fibrosis[J]. Cell, 2008, 134 (4) :657-667.

[50] PETRASEK J, IRACHETAVELLVE A, CSAK T, et al. STINGIRF3 pathway links endoplasmic reticulum stress with hepatocyte apoptosis in early alcoholic liver disease[J]. PNAS, 2013, 110 (41) :16544-16549.

[51] IRACHETA-VELLVE A, PETRASEK J, GYONGYOSI B, et al.Endoplasmic reticulum stress-induced hepatocellular death pathways mediate liver injury and fibrosis via stimulator of interferon genes[J]. J Biol Chem, 2016, 291 (52) :26794-26805.

[52] IURESCIA S, FIORETTI D, RINALDI M. Targeting cytosolic nucleic acid-sensing pathways for cancer immunotherapies[J]. Front Immunol, 2018, 9:711.

[53] SANDRA IURESCIA DF, RINALDI M. Nucleic acid sensing machinery:Targeting innate immune system for cancer therapy[J]. Recent Pat Anticancer Drug Discov, 2018, 13 (1) :2-17.

[54] GADKAREE SK, FU J, SEN R, et al. Induction of tumor regression by intratumoral STING agonists combined with anti–programmed death-L1 blocking antibody in a preclinical squamous cell carcinoma model[J]. Head Neck, 2017, 39 (6) :1086-1094.

[55] TANG CA, ZUNDELL JA, RANATUNGA S, et al. Agonistmediated activation of STING induces apoptosis in malignant B cells[J]. Cancer Res, 2016, 76 (8) :2137-2152.

[56] FU J, KANNE DB, LEONG M, et al. STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade[J]. Sci Transl Med, 2015, 7 (283) :283ra52.

[57] ZEVINI A, OLAGNIER D, HISCOTT J. Crosstalk between cytoplasmic RIG-I and STING sensing pathways[J]. Trends Immunol, 2017, 38 (3) :194-205.

[58] KHOO LT, CHEN LY. Role of the cGAS-STING pathway in cancer development and oncotherapeutic approaches[J].EMBO Rep, 2018, 19 (12) :e46935.

[59] GLÜCK S, GUEY B, GULEN MF, et al. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence[J]. Nat Cell Biol, 2017, 19 (9) :1061-1070.

[60] DOU Z, GHOSH K, VIZIOLI MG, et al. Cytoplasmic chromatin triggers inflammation in senescence and cancer[J]. Nature, 2017, 550 (7676) :402-406.

[61] BU Y, LIU F, JIA QA, et al. Decreased expression of TMEM173predicts poor prognosis in patients with hepatocellular carcinoma[J]. PLo S One, 2016, 11 (11) :e0165681.

[62] LI T, CHEN ZJ. The cGAS-cGAMP-STING pathway connects DNA damage to inflammation, senescence, and cancer[J]. J Exp Med, 2018, 215 (5) :1287-1299.

[63] GALLUZZI L, BUQUA, KEPP O, et al. Immunogenic cell death in cancer and infectious disease[J]. Nat Rev Immunol, 2017, 17 (2) :97-111.

施引文献

资源附件(0)

访问统计